The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CTXR FINANCIAL STATEMENTS

Citius Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

CTXRCitius Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-40 M-20 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue7.1 M $Gross Profit3.1 M $ · 44%Operating Income-60.9 M $ · -857%Pre-tax Income-58 M $ · -816%Net Income to Owners-49.3 M $ · -694%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue7.1 M $+2,178.4%
Gross Profit3.1 M $—
Operating Income-60.9 M $—
EBITDA-58.4 M $—
Net Income to Owners-49.3 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 M100 M150 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets142.3 M
  • Equity66.6 M $50%
  • Current Liabilities51.6 M $39%
  • Long-term Liabilities14.7 M $11%

Key Figures

YoY change
Total Assets142.3 M $+11.4%
Total Liabilities66.3 M $+10.4%
Total Equity66.6 M $+2.4%
Cash & ST Investments17 M $+179.3%
Total Debt7.2 M $+281.4%
Net Debt-9.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-20 M0-26.2 M $Operating-10.8 M $Investing35.4 M $Financing-1.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-26.2 M $—
Capital Expenditures4 $+0.0%
Free Cash Flow-26.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CTXR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.